These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24845118)

  • 1. Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders.
    Streck EL; Gonçalves CL; Furlanetto CB; Scaini G; Dal-Pizzol F; Quevedo J
    Braz J Psychiatry; 2014; 36(2):156-67. PubMed ID: 24845118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction and psychiatric disorders.
    Rezin GT; Amboni G; Zugno AI; Quevedo J; Streck EL
    Neurochem Res; 2009 Jun; 34(6):1021-9. PubMed ID: 18979198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant Action on Mitochondrial Dysfunction in Psychiatric Disorders.
    Adzic M; Brkic Z; Bulajic S; Mitic M; Radojcic MB
    Drug Dev Res; 2016 Nov; 77(7):400-406. PubMed ID: 27539538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction and psychiatric disorders.
    Jou SH; Chiu NY; Liu CS
    Chang Gung Med J; 2009; 32(4):370-9. PubMed ID: 19664343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.
    Clay HB; Sillivan S; Konradi C
    Int J Dev Neurosci; 2011 May; 29(3):311-24. PubMed ID: 20833242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial involvement in psychiatric disorders.
    Shao L; Martin MV; Watson SJ; Schatzberg A; Akil H; Myers RM; Jones EG; Bunney WE; Vawter MP
    Ann Med; 2008; 40(4):281-95. PubMed ID: 18428021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Dysfunctions in Bipolar Disorder: Effect of the Disease and Pharmacotherapy.
    Cikankova T; Sigitova E; Zverova M; Fisar Z; Raboch J; Hroudova J
    CNS Neurol Disord Drug Targets; 2017; 16(2):176-186. PubMed ID: 27978794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mitochondrial dysfunction in psychiatric disease.
    Scaglia F
    Dev Disabil Res Rev; 2010; 16(2):136-43. PubMed ID: 20818728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.
    Morris G; Berk M
    BMC Med; 2015 Apr; 13():68. PubMed ID: 25889215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.
    Kim Y; Vadodaria KC; Lenkei Z; Kato T; Gage FH; Marchetto MC; Santos R
    Antioxid Redox Signal; 2019 Aug; 31(4):275-317. PubMed ID: 30585734
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitochondrial Involvement in Mental Disorders: Energy Metabolism and Genetic and Environmental Factors.
    Iwata K
    Adv Exp Med Biol; 2019; 1118():63-70. PubMed ID: 30747417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases.
    Wu YT; Wu SB; Wei YH
    Curr Pharm Des; 2014; 20(35):5510-26. PubMed ID: 24606797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial alterations and neuropsychiatric disorders.
    Marazziti D; Baroni S; Picchetti M; Landi P; Silvestri S; Vatteroni E; Catena Dell'Osso M
    Curr Med Chem; 2011; 18(30):4715-21. PubMed ID: 21864278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric Features in Primary Mitochondrial Disease.
    Marin SE; Saneto RP
    Neurol Clin; 2016 Feb; 34(1):247-94. PubMed ID: 26614002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention.
    Rossetti AC; Paladini MS; Riva MA; Molteni R
    Pharmacol Ther; 2020 Jun; 210():107520. PubMed ID: 32165136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial response to controlled nutrition in health and disease.
    Schiff M; Bénit P; Coulibaly A; Loublier S; El-Khoury R; Rustin P
    Nutr Rev; 2011 Feb; 69(2):65-75. PubMed ID: 21294740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mitochondrial genome and psychiatric illness.
    Anglin RE; Mazurek MF; Tarnopolsky MA; Rosebush PI
    Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):749-59. PubMed ID: 22887963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of mitochondrial dysfunction in bipolar disorder.
    Kato T
    Drug News Perspect; 2006 Dec; 19(10):597-602. PubMed ID: 17299601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.